Elucid is a Boston-based medical technology company that specializes in using histology-validated software to optimize treatment decisions for patients with cardiovascular disease. Their key offerings include plaque characterization, fractional flow reserve (FFRct) analysis, and CT angiography, providing physicians with advanced clinical insights to enable precision medicine. Elucid stands out by offering the first non-invasive software to quantify atherosclerotic plaque characteristics, leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
Join a rapidly growing medical technology company using AI to enable clinicians to make informed decisions on cardiovascular care, working on software systems that power AI-driven medical imaging platform, and collaborate with machine learning and visualization engineers.
Elucid is a Boston-based medical technology company that specializes in using histology-validated software to optimize treatment decisions for patients with cardiovascular disease. Their key offerings include plaque characterization, fractional flow reserve (FFRct) analysis, and CT angiography, providing physicians with advanced clinical insights to enable precision medicine. Elucid stands out by offering the first non-invasive software to quantify atherosclerotic plaque characteristics, leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
4DMedical